Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Radiocontrast Agent Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Radiocontrast Agent Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Barium-based Radiocontrast Agent
      • 1.3.3 Iodinated Radiocontrast Agent
      • 1.3.4 Gadolinium-based Radiocontrast Agent
      • 1.3.5 Microbubble Radiocontrast Agent
    • 1.4 Market Segment by Application
      • 1.4.1 Global Radiocontrast Agent Market Share by Application (2019-2025)
      • 1.4.2 Radiology
      • 1.4.3 Interventional Radiology
      • 1.4.4 Interventional Cardiology
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Radiocontrast Agent Production Value 2014-2025
      • 2.1.2 Global Radiocontrast Agent Production 2014-2025
      • 2.1.3 Global Radiocontrast Agent Capacity 2014-2025
      • 2.1.4 Global Radiocontrast Agent Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Radiocontrast Agent Market Size CAGR of Key Regions
      • 2.2.2 Global Radiocontrast Agent Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Radiocontrast Agent Capacity by Manufacturers
      • 3.1.2 Global Radiocontrast Agent Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Radiocontrast Agent Revenue by Manufacturers (2014-2019)
      • 3.2.2 Radiocontrast Agent Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Radiocontrast Agent Market Concentration Ratio (CR5 and HHI)
    • 3.3 Radiocontrast Agent Price by Manufacturers
    • 3.4 Key Manufacturers Radiocontrast Agent Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Radiocontrast Agent Market
    • 3.6 Key Manufacturers Radiocontrast Agent Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Barium-based Radiocontrast Agent Production and Production Value (2014-2019)
      • 4.1.2 Iodinated Radiocontrast Agent Production and Production Value (2014-2019)
      • 4.1.3 Gadolinium-based Radiocontrast Agent Production and Production Value (2014-2019)
      • 4.1.4 Microbubble Radiocontrast Agent Production and Production Value (2014-2019)
    • 4.2 Global Radiocontrast Agent Production Market Share by Type
    • 4.3 Global Radiocontrast Agent Production Value Market Share by Type
    • 4.4 Radiocontrast Agent Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Radiocontrast Agent Consumption by Application

    6 Production by Regions

    • 6.1 Global Radiocontrast Agent Production (History Data) by Regions 2014-2019
    • 6.2 Global Radiocontrast Agent Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Radiocontrast Agent Production Growth Rate 2014-2019
      • 6.3.2 United States Radiocontrast Agent Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Radiocontrast Agent Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Radiocontrast Agent Production Growth Rate 2014-2019
      • 6.4.2 European Union Radiocontrast Agent Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Radiocontrast Agent Import & Export
    • 6.5 China
      • 6.5.1 China Radiocontrast Agent Production Growth Rate 2014-2019
      • 6.5.2 China Radiocontrast Agent Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Radiocontrast Agent Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Radiocontrast Agent Consumption by Regions

    • 7.1 Global Radiocontrast Agent Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Radiocontrast Agent Consumption by Type
      • 7.2.2 United States Radiocontrast Agent Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Radiocontrast Agent Consumption by Type
      • 7.3.2 European Union Radiocontrast Agent Consumption by Application
    • 7.4 China
      • 7.4.1 China Radiocontrast Agent Consumption by Type
      • 7.4.2 China Radiocontrast Agent Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Radiocontrast Agent Consumption by Type
      • 7.5.2 Rest of World Radiocontrast Agent Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 GE Healthcare (US)
      • 8.1.1 GE Healthcare (US) Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Radiocontrast Agent
      • 8.1.4 Radiocontrast Agent Product Introduction
      • 8.1.5 GE Healthcare (US) Recent Development
    • 8.2 Bracco Imaging (Italy)
      • 8.2.1 Bracco Imaging (Italy) Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Radiocontrast Agent
      • 8.2.4 Radiocontrast Agent Product Introduction
      • 8.2.5 Bracco Imaging (Italy) Recent Development
    • 8.3 Bayer HealthCare (Germany)
      • 8.3.1 Bayer HealthCare (Germany) Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Radiocontrast Agent
      • 8.3.4 Radiocontrast Agent Product Introduction
      • 8.3.5 Bayer HealthCare (Germany) Recent Development
    • 8.4 Guerbet (France)
      • 8.4.1 Guerbet (France) Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Radiocontrast Agent
      • 8.4.4 Radiocontrast Agent Product Introduction
      • 8.4.5 Guerbet (France) Recent Development
    • 8.5 Lantheus (US)
      • 8.5.1 Lantheus (US) Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Radiocontrast Agent
      • 8.5.4 Radiocontrast Agent Product Introduction
      • 8.5.5 Lantheus (US) Recent Development
    • 8.6 Daiichi Sankyo (Japan)
      • 8.6.1 Daiichi Sankyo (Japan) Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Radiocontrast Agent
      • 8.6.4 Radiocontrast Agent Product Introduction
      • 8.6.5 Daiichi Sankyo (Japan) Recent Development
    • 8.7 Unijules Life Sciences (India)
      • 8.7.1 Unijules Life Sciences (India) Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Radiocontrast Agent
      • 8.7.4 Radiocontrast Agent Product Introduction
      • 8.7.5 Unijules Life Sciences (India) Recent Development
    • 8.8 J.B. Chemicals and Pharmaceuticals (India)
      • 8.8.1 J.B. Chemicals and Pharmaceuticals (India) Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Radiocontrast Agent
      • 8.8.4 Radiocontrast Agent Product Introduction
      • 8.8.5 J.B. Chemicals and Pharmaceuticals (India) Recent Development
    • 8.9 Spago Nanomedicine (Sweden)
      • 8.9.1 Spago Nanomedicine (Sweden) Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Radiocontrast Agent
      • 8.9.4 Radiocontrast Agent Product Introduction
      • 8.9.5 Spago Nanomedicine (Sweden) Recent Development
    • 8.10 Taejoon Pharm (South Korea)
      • 8.10.1 Taejoon Pharm (South Korea) Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Radiocontrast Agent
      • 8.10.4 Radiocontrast Agent Product Introduction
      • 8.10.5 Taejoon Pharm (South Korea) Recent Development
    • 8.11 Jodas (India)
    • 8.12 Magnus Health (India)

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Radiocontrast Agent Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Radiocontrast Agent Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Radiocontrast Agent Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Radiocontrast Agent Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Radiocontrast Agent Production Forecast by Type
      • 9.7.2 Global Radiocontrast Agent Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Radiocontrast Agent Sales Channels
      • 10.2.2 Radiocontrast Agent Distributors
    • 10.3 Radiocontrast Agent Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Radiocontrast Agent is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Radiocontrast Agent.

      This report studies the global market size of Radiocontrast Agent, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Radiocontrast Agent production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      GE Healthcare (US)
      Bracco Imaging (Italy)
      Bayer HealthCare (Germany)
      Guerbet (France)
      Lantheus (US)
      Daiichi Sankyo (Japan)
      Unijules Life Sciences (India)
      J.B. Chemicals and Pharmaceuticals (India)
      Spago Nanomedicine (Sweden)
      Taejoon Pharm (South Korea)
      Jodas (India)
      Magnus Health (India)

      Market Segment by Product Type
      Barium-based Radiocontrast Agent
      Iodinated Radiocontrast Agent
      Gadolinium-based Radiocontrast Agent
      Microbubble Radiocontrast Agent

      Market Segment by Application
      Radiology
      Interventional Radiology
      Interventional Cardiology

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Radiocontrast Agent status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Radiocontrast Agent manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Radiocontrast Agent are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now